Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001295947-25-000009
Filing Date
2025-02-06
Accepted
2025-02-06 06:08:58
Documents
86
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q pbh-20241231.htm   iXBRL 10-Q 1496727
2 EX-31.1 exhibit3112024-12x31.htm EX-31.1 11288
3 EX-31.2 exhibit3122024-12x31.htm EX-31.2 11168
4 EX-32.1 exhibit3212024-12x31.htm EX-32.1 5365
5 EX-32.2 exhibit3222024-12x31.htm EX-32.2 5290
11 pbh-20241231_g1.jpg GRAPHIC 66137
  Complete submission text file 0001295947-25-000009.txt   8420668

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pbh-20241231.xsd EX-101.SCH 52891
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pbh-20241231_cal.xml EX-101.CAL 110972
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pbh-20241231_def.xml EX-101.DEF 202345
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pbh-20241231_lab.xml EX-101.LAB 700786
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pbh-20241231_pre.xml EX-101.PRE 465830
89 EXTRACTED XBRL INSTANCE DOCUMENT pbh-20241231_htm.xml XML 1422336
Mailing Address 660 WHITE PLAINS RD. TARRYTOWN NY 10591
Business Address 660 WHITE PLAINS RD. TARRYTOWN NY 10591 (914) 524-6800
Prestige Consumer Healthcare Inc. (Filer) CIK: 0001295947 (see all company filings)

EIN.: 201297589 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-32433 | Film No.: 25595288
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)